His main research concerns Immunology, Antibody, Receptor, Immunoglobulin G and Immune system. Falk Nimmerjahn has researched Immunology in several fields, including Pathology and Cell biology. His Antibody study incorporates themes from Myeloid, Pharmacology and In vivo.
His Receptor research includes themes of Effector, Glycosylation, Monoclonal antibody and Glycan. Falk Nimmerjahn interconnects Plasma cell, Molecular biology, Fc receptor, Fc-Gamma Receptor and Fragment crystallizable region in the investigation of issues within Immunoglobulin G. His study in the field of Immune receptor, Immunity and C5a receptor is also linked to topics like Syk.
His primary areas of investigation include Immunology, Antibody, Receptor, Immune system and Immunoglobulin G. Falk Nimmerjahn has included themes like Molecular biology, Glycosylation, In vivo and Effector in his Antibody study. His study in Glycosylation is interdisciplinary in nature, drawing from both IgG binding and Glycan.
His work investigates the relationship between Receptor and topics such as Cell biology that intersect with problems in Antigen Targeting and Dendritic cell. The study incorporates disciplines such as Osteoclast, Isotype, Antigen and Cancer research in addition to Immune system. His research in Immunoglobulin G intersects with topics in Sialic acid, Subclass, Antibody-dependent cell-mediated cytotoxicity, Internal medicine and Macrophage.
Falk Nimmerjahn focuses on Antibody, Receptor, Immunology, Immune system and Cell biology. His Antibody research incorporates themes from Glycosylation, Phagocytosis and Effector. His biological study spans a wide range of topics, including Lyme Arthritis, Pathogen, Immunoglobulin G, Gene and Self reactive antibody.
In his study, which falls under the umbrella issue of Immunoglobulin G, Pathogenesis is strongly linked to N-linked glycosylation. His studies in Immune system integrate themes in fields like Cancer research, Isotype, Arthritis, Antigen and Rheumatoid arthritis. His studies deal with areas such as Dendritic cell, Antigen Targeting, Fc receptor, Cell killing and Monoclonal antibody as well as Cell biology.
His main research concerns Antibody, Immunology, Immune system, Receptor and Cell biology. His work carried out in the field of Antibody brings together such families of science as Etanercept and Peptide. His Immunology research is multidisciplinary, incorporating perspectives in Recombinant factor viii and Drug.
As a member of one scientific family, he mostly works in the field of Immune system, focusing on Effector and, on occasion, Phagocytosis, Immunity and Polyclonal antibodies. His Receptor study integrates concerns from other disciplines, such as Cell type, Peripheral blood and Haplotype. The concepts of his Cell biology study are interwoven with issues in Immunoglobulin G, Fc receptor and Monoclonal antibody.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Fcγ receptors as regulators of immune responses
Falk Nimmerjahn;Jeffrey V. Ravetch.
Nature Reviews Immunology (2008)
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Yoshikatsu Kaneko;Falk Nimmerjahn;Jeffrey V. Ravetch.
Science (2006)
Fcγ Receptors: Old Friends and New Family Members
Falk Nimmerjahn;Jeffrey V. Ravetch.
Immunity (2006)
Divergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding
Falk Nimmerjahn;Jeffrey V. Ravetch.
Science (2005)
Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc
Robert M. Anthony;Falk Nimmerjahn;Falk Nimmerjahn;David J. Ashline;Vernon N. Reinhold.
Science (2008)
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
Ulrike Harre;Dan Georgess;Holger Bang;Aline Bozec.
Journal of Clinical Investigation (2012)
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?
Inessa Schwab;Falk Nimmerjahn.
Nature Reviews Immunology (2013)
FcγRIV : A novel FcR with distinct IgG subclass specificity
Falk Nimmerjahn;Pierre Bruhns;Ken Horiuchi;Jeffrey V. Ravetch.
Immunity (2005)
Anti-Inflammatory Actions of Intravenous Immunoglobulin
Falk Nimmerjahn;Jeffrey V Ravetch.
Annual Review of Immunology (2008)
Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate.
Hanne Schoenen;Barbara Bodendorfer;Kelly Hitchens;Silvia Manzanero.
Journal of Immunology (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Rockefeller University
University of Erlangen-Nuremberg
University of Erlangen-Nuremberg
University of Lübeck
University of Lübeck
University of Geneva
Leiden University Medical Center
Ludwig-Maximilians-Universität München
University of Lübeck
University of Freiburg
University of Tokyo
The University of Texas at El Paso
Antleron
Chinese Academy of Sciences
Hebrew University of Jerusalem
Technical University of Darmstadt
University of Bristol
Shanghai Jiao Tong University
University of Toronto
Animal and Plant Health Agency
University of Modena and Reggio Emilia
University of Washington
Wake Forest University
University of Pennsylvania
KU Leuven
Boston University